Age-Appropriateness of Oral Formulations Authorized for Pediatrics
Significant formulation gaps persist in pediatric medicine, with acceptability and excipient safety presenting highest risk. The potential of non-conventional solid dosage forms remains underutilized, underscoring the need for regulatory frameworks to support development of pediatric medicines.
Authors
- Hala M. Fadda (ORCID: https://orcid.org/0000-0002-7668-1426)
- Lauren M. Le
- Hannah R. Weiler
Institutions
- Butler University (US)
Publication Details
- Journal
- Pharmaceutical Research
- Published
- 2026-03-16
- DOI
- https://doi.org/10.1007/s11095-026-04055-x
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00